451 / 1195
What we know right now…
IMRT is a new
tool,
and
continues to evolve:
New skills, attention to details
Affects all aspects of treatment, not just planning
IMRT creates
‘
different
’
dose distributions
which
can be
‘
superior
’
:
But this relies on upstream information that allow
clinical assertions to be informed and correct.
It also relies on the capacity to administer the
therapy correctly.
Clinical evidence to date supports the
“
superior
dosimetry, superior outcomes
”
hypothesis in
most sites